Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis

BACKGROUND: Since the introduction of rhBMP-2 (Infuse®) in 2002, surgeons have had an alternative substitute to autograft and its related donor site morbidity. Recently, the prevalence of reported adverse events and complications related to the use of rhBMP-2 has raised many ethical and legal concer...

Descripción completa

Detalles Bibliográficos
Autores principales: Roh, Jeffrey S, Yeung, Christopher A, Field, Justin S, McClellan, R Trigg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916062/
https://www.ncbi.nlm.nih.gov/pubmed/24373225
http://dx.doi.org/10.1186/1749-799X-8-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916062/
https://www.ncbi.nlm.nih.gov/pubmed/24373225
http://dx.doi.org/10.1186/1749-799X-8-49

Ejemplares similares